Tim Garver
![](https://synergbiopharma.com/wp-content/uploads/2024/06/Featured-image-syner-g-768x390.jpg)
Planning Your NDA or BLA Submission: It’s More Than a Gantt Chart!
February 25, 2016 | Tim Garver, PhD, Executive VP and Chief Operating Officer | Medical Writing Services You’re finally there! You and your colleagues find yourself at the doorstep of being able to submit either a New Drug Application (NDA)…